↓ Skip to main content

The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems

Overview of attention for article published in Frontiers in oncology, January 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
Published in
Frontiers in oncology, January 2022
DOI 10.3389/fonc.2021.704999
Pubmed ID
Authors

Luyao Wang, Yurong Chen, Xinrui Liu, Ziyi Li, Xiangpeng Dai

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 10%
Researcher 4 8%
Student > Bachelor 3 6%
Lecturer 1 2%
Student > Doctoral Student 1 2%
Other 3 6%
Unknown 32 65%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 12%
Agricultural and Biological Sciences 5 10%
Medicine and Dentistry 3 6%
Immunology and Microbiology 2 4%
Unspecified 1 2%
Other 0 0%
Unknown 32 65%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 February 2022.
All research outputs
#7,638,838
of 26,166,431 outputs
Outputs from Frontiers in oncology
#2,716
of 22,913 outputs
Outputs of similar age
#165,705
of 529,388 outputs
Outputs of similar age from Frontiers in oncology
#147
of 1,402 outputs
Altmetric has tracked 26,166,431 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 529,388 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 1,402 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.